A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia

Haematologica. 2001 Jan;86(1):102-3.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / adverse effects
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Middle Aged
  • Myelodysplastic Syndromes / chemically induced*
  • Neoplasms, Second Primary / chemically induced
  • Topoisomerase II Inhibitors

Substances

  • Enzyme Inhibitors
  • Topoisomerase II Inhibitors